Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . (CORE-HIV)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Universidad de Valparaiso
Sponsor:
Collaborators:
Roche Pharma AG
GlaxoSmithKline
Aclin Laboratories, Chile
Information provided by (Responsible Party):
Felipe Martinez, Universidad de Valparaiso
ClinicalTrials.gov Identifier:
NCT02003703
First received: December 2, 2013
Last updated: October 24, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)